Nasal Swab Test Detects Early Alzheimer’s Signals, Study Finds

Duke Health researchers have announced a potential breakthrough in Alzheimer’s disease detection: a quick nasal swab test that can identify biological changes associated with the condition even before symptoms appear. This offers hope for earlier intervention and potentially more effective treatments.

How the Nasal Swab Test Works

The fresh test analyzes cells collected from a gentle swab inserted high into the nose. Researchers found that analyzing these cells revealed clear patterns that distinguished individuals with early or diagnosed Alzheimer’s from those without the disease. The procedure takes just a few minutes, involving a numbing spray followed by a clinician guiding a small brush into the upper nasal cavity, where smell-detecting nerve cells reside. These cells are then examined to determine which genes are active, providing insights into brain activity.

The study, published in Nature Communications on March 18, 2026, compared gene activity across thousands of individual cells from 22 participants, generating millions of data points. The swab successfully detected early shifts in nerve and immune cells, even in individuals who showed no cognitive symptoms but had lab-based signs of Alzheimer’s.

A combined nose tissue gene score, summarizing gene activity in nasal tissue, accurately separated early and clinical Alzheimer’s from healthy controls approximately 81% of the time.

A New Approach to Alzheimer’s Diagnosis

Current Alzheimer’s diagnostic methods, including blood tests, often detect markers that appear later in the disease process. In contrast, the nasal swab captures living nerve and immune activity, potentially offering an earlier and more direct assessment of disease-related changes. This could help identify individuals at risk sooner and allow for earlier intervention.

“We want to be able to confirm Alzheimer’s remarkably early, before damage has a chance to build up in the brain,” said Bradley J. Goldstein, M.D., Ph.D., corresponding author and professor in the departments of Head and Neck Surgery & Communication Sciences, Cell Biology and Neurobiology at Duke University School of Medicine. “If we can diagnose people early enough, we might be able to start therapies that prevent them from ever developing clinical Alzheimer’s.”

Vincent M. D’Anniballe, the study’s first author and a student in the Medical Scientist Training Program at Duke, noted, “Much of what we grasp about Alzheimer’s comes from autopsy tissue. Now we can study living neural tissue, opening new possibilities for diagnosis and treatment.”

The Connection Between Smell and Alzheimer’s

The nose has long been recognized as a potential indicator of Alzheimer’s disease, as a loss of smell is often an early symptom. The olfactory lining in the upper nasal cavity contains nerve cells directly connected to the brain. Researchers hypothesized that cells from this region could serve as a proxy for cells deeper within the brain affected by the accumulation of proteins like amyloid and tau, hallmarks of Alzheimer’s disease.

This research builds on growing understanding of the link between olfactory dysfunction and Alzheimer’s pathology, offering a less invasive and more accessible method for early detection.